Last reviewed · How we verify
NCT03727737
Efficacy of Repetitive Transcranial Magnetic Stimulation for Improvement of Memory in Older Adults With TBI
NA trial testing Repetitive Transcranial magnetic Stimulation in Brain Injuries, Traumatic in 33 participants. Completed in 14 September 2022.
14 September 2022
Quick facts
| Lead sponsor | Palo Alto Veterans Institute for Research |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | treatment |
| Enrollment | 33 |
| Start date | 23 October 2018 |
| Primary completion | 14 September 2022 |
| Estimated completion | 14 September 2022 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Repetitive Transcranial magnetic Stimulation
Conditions studied
- Brain Injuries, Traumatic — all drugs for Brain Injuries, Traumatic →
- Repetitive Transcranial Magnetic Stimulation — all drugs for Repetitive Transcranial Magnetic Stimulation →
- Memory Deficits — all drugs for Memory Deficits →
- Aging — all drugs for Aging →
Sponsor
Palo Alto Veterans Institute for Research
Who can join
Adults 50 to 75, any sex, with Brain Injuries, Traumatic or Repetitive Transcranial Magnetic Stimulation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The proposed study will evaluate the safety, durability and efficacy of repetitive Transcranial Magnetic Stimulation (rTMS) as a promising non-invasive therapeutic treatment for improving memory in older adults with mild or moderate Traumatic Brain Injury (TBI) who have been experiencing residual memory or cognitive problems that affect daily functioning.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03727737
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Brain Injuries, Traumatic
Currently open trials in the same condition.
- NCT06898242 — Early Myofascial Manual Treatment in Subjects With Spasticity Following Acquired Brain Injury · NA · active not recruiting
- NCT06413173 — Remotely Supervised tDCS+ for Complex Attention in mTBI (Cognetric) · NA · recruiting
- NCT06142435 — mTBI Identification and Monitoring Through Retinal Scanning · recruiting
- NCT05117619 — The HOME Program for Individuals With Traumatic Brain Injury and Family Members · NA · recruiting
- NCT05092295 — Head and Intraocular Trauma Tool for the Identification of Mild Traumatic Brain Injury · active not recruiting
Other Palo Alto Veterans Institute for Research trials
Trials by the same sponsor.
- NCT07219251 — Engagement of Veterans With Lung Cancer · NA · recruiting
- NCT06704061 — Online Yoga vs Acceptance and Commitment Therapy for Treating Chronic Musculoskeletal Pain · NA · recruiting
- NCT07069517 — Accelerated Treatment for Co-occurring Insomnia, Nightmares, and PTSD · NA · recruiting
- NCT07303725 — Intra-procedural Spectral CT for Image-guided Embolization and Ablation in Interventional Oncology · recruiting
- NCT07303712 — Liquid Biopsy for Hepatocellular Carcinoma Molecular Characterization After Y90 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03727737 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Palo Alto Veterans Institute for Research
- Last refreshed: 11 April 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03727737.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing